English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessMarketsCipla's strong US pipeline, steady Q4 earnings and hopes of easing regulatory snags drive bullishness

    Cipla's strong US pipeline, steady Q4 earnings and hopes of easing regulatory snags drive bullishness

    Cipla plans to launch 12 assets in peptides and complex generics space and 5 in the respiratory segment over FY25-27, which brokerages believe will secure its growth path for the next 3-4 years.

    Vaibhavi Ranjan
    May 13, 2024 / 11:44 IST
    Cipla's Q4 net profit topped estimates but revenue slightly lagged expectations.
    • PRO Panorama

      Moneycontrol Pro Panorama | Tariff noise, empty vessel?

      Oct 17, 2025 / 02:40 PM IST

      For Moneycontrol's Pro Panorama October 17 edition: Tea drinkers rejoice but growers balk at price side, decoding India's trade de...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts